IRIS
FAZIA, Maria Luigia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 819
EU - Europa 748
AS - Asia 307
Totale 1.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 817
UA - Ucraina 152
CN - Cina 133
SE - Svezia 121
IE - Irlanda 120
TR - Turchia 111
GB - Regno Unito 100
FR - Francia 90
IT - Italia 80
IN - India 51
DE - Germania 42
FI - Finlandia 26
BE - Belgio 9
SG - Singapore 7
RU - Federazione Russa 4
CA - Canada 2
IL - Israele 2
IR - Iran 2
NL - Olanda 2
CZ - Repubblica Ceca 1
NO - Norvegia 1
VN - Vietnam 1
Totale 1.874
Salva come PNG Salva come JPEG
Città #
Chandler 187
Jacksonville 150
Dublin 119
Southend 70
Ann Arbor 54
Ashburn 54
Izmir 52
Princeton 50
Nanjing 36
Chieti 32
New York 30
Wilmington 29
Beijing 25
Cambridge 24
Altamura 21
Woodbridge 20
Dearborn 17
Washington 16
Nanchang 15
Boardman 9
Brussels 9
Tianjin 9
Kunming 7
Auburn Hills 6
Grevenbroich 6
Los Angeles 6
Hebei 5
Hefei 5
Shenyang 5
Singapore 5
Augusta 4
Hangzhou 4
Norwalk 4
Orange 4
Zhengzhou 4
Foggia 3
Hanover 3
Jiaxing 3
Jinan 3
Lanzhou 3
Milan 3
Pescara 3
San Mateo 3
Seattle 3
Changsha 2
Guangzhou 2
Kocaeli 2
Monmouth Junction 2
Rome 2
San Salvo 2
Taizhou 2
Toronto 2
Tortoreto 2
Ardabil 1
Binh Duong 1
Fairfield 1
Helsinki 1
Houston 1
Inveruno 1
Killorglin 1
Leawood 1
Mumbai 1
Ningbo 1
Paris 1
Penne 1
Prague 1
Simi Valley 1
Southgate 1
Totale 1.153
Salva come PNG Salva come JPEG
Nome #
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 108
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 99
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 98
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 94
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 89
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 87
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 85
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 83
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 80
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 76
Association between 5-lipoxygenase expression and plaque instability in humans. 76
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 74
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 74
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 72
Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk. 71
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 69
COX-2 expression in atherosclerosis: the good, the bad or the ugly? 69
Novel determinants of plaque instability. 68
Role of angiotensin II receptor blockers in atherosclerotic plaque stability. 65
Enhanced soluble CD40 ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control 65
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 64
COX-2 and atherosclerosis. 63
Fisiopatologia della placca aterosclerotica 61
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control 55
New insights on the molecular mechanisms of type-1 angiotensin II receptor blockers and their contribution to atherosclerotic plaque stabilization 54
Totale 1.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 2 1 64
2019/2020346 106 25 3 21 10 16 38 34 12 28 48 5
2020/2021190 27 0 28 2 19 38 4 0 22 30 9 11
2021/2022128 5 1 2 33 11 2 6 7 8 9 15 29
2022/2023461 30 73 25 62 51 81 20 28 64 3 12 12
2023/2024221 12 6 26 2 21 98 45 4 3 4 0 0
Totale 1.899